| Description: | Episodes containing "Treatment speciality of consultant" data (recoded) |
| Category: | Health outcomes ⏵ Externally sourced health outcomes ⏵ Hospital inpatient |
| Linked health outcomes |
| Participants | 413,150 | Value Type | Integer, records | Sexed | Both sexes | Debut | Jun 2013 | |||
| Item count | 413,150 | Item Type | Records | Instances | Singular | Version | Mar 2019 | |||
| Stability | Accruing | Strata | Primary | Array | No | Cost Tier | o1 sX |
Field is currently retired.
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
|
|
|
The treatment speciality of the consultant is specialism under which the consultant was working e.g. cardiology or geriatric medicine, etc.
In order to conduct analyses using this information, researchers must include this data-field in their application, however access will be given in-situ rather than as a download.
Note that the original information was obtained from a variety of external sources, some of which used overlapping and contradictory coding schemes. This field has been re-coded to remove such data conflicts (the original data equivalent is available as Field 41112).
| Preview | Name | Res ID |
|---|---|---|
 | HES Data Dictionary | 141140 |
 | Hospital Episode Statistics | 138483 |
 | Mapping inpatient hospital data across England, Scotland and Wales | 146641 |
| Application ID | Title |
|---|---|
| 69597 | Association of Noise Pollution and Cardiometabolic Disease |
| 9310 | Associations of blood biomarkers with cardiovascular disease and related cardiometabolic outcomes and risk prediction in the clinical setting |
| 19056 | Copy-number variants in Cardiovascular and Neuropsychiatric disorders |
| 26629 | Cross-cultural variations in female reproductive health and non-communicable diseases: analysis of 500,000 participants from the UKBiobank and the InterLACE consortium |
| 21552 | Detection of large-scale copy-number and copy-neutral mosaic alterations in circulating leukocyte DNA of UK Biobank cancer cases and cancer-free controls |
| 23183 | Dietary iron intake and public health risk |
| 48818 | Evaluate the causal effects of diet-modifiable biomarkers on clinical outcomes using Mendelian randomization |
| 13352 | Evaluation of Association of TRPV4 Variation with Heart Failure, Respiratory, Renal and Menstruation Phenotypes |
| 27034 | Evaluation of genetic and non-genetic risk factors for degenerative rotator cuff disease. |
| 7089 | Exome Sequencing of All Premature Coronary Artery Disease Participants in UK Biobank |
| 61650 | Genetic variation in sodium-glucose cotransporter 2 (SGLT2) and glucagon-like peptide-1 receptor (GLP1R) and cardiovascular outcomes |
| 25205 | Identification and characterization of functional variants with a causal role in chronic cardiopulmonary diseases |
| 8294 | Identifying environmental and genetic risk factors for endometrial cancer subtypes |
| 40644 | Investigating aetiology, associations and causality in diseases of the head and neck |
| 19136 | Lung Health: Genes and environment |
| 46466 | Serum cardiometabolic and liver function markers in relation to colorectal cancer risk and survival |
| 52217 | Serum cardiometabolic biomarkers in relation to all-cause and cause-specific mortality |
| 14801 | Social isolation and health - what are the mechanisms? |
| 40086 | The association of type 2 diabetes and HbA1c with subsequent risk of cancer at different anatomical sites |
| 3913 | The genetics of HbA1c: biological pathways and impact on diabetes and cardiovascular disease risk. |
| 15008 | The impact of smoking, alcohol and adiposity on health outcomes in the UK Biobank |
| 22783 | The joint analysis of imaging data and genetic data for early tumor detection, prevention, diagnosis and treatment |
| 17488 | Understanding the Genetic Basis of Cardiac Arrhythmias |
| 20684 | Understanding the associations between environmental exposures, health behaviours and health outcomes |
| 41686 | Understanding the biological, lifestyle and environmental risks and outcomes for multimorbidity in psychiatric disorders |
Enabling scientific discoveries that improve human health